PMID- 38098894 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231216 IS - 2168-8184 (Print) IS - 2168-8184 (Electronic) IS - 2168-8184 (Linking) VI - 15 IP - 11 DP - 2023 Nov TI - Acute Hepatitis E-Associated Guillain-Barre Syndrome. PG - e48778 LID - 10.7759/cureus.48778 [doi] LID - e48778 AB - Guillain-Barre syndrome (GBS) is a rare autoimmune disorder of the peripheral nervous system that causes progressive weakness and sensory disturbances, usually following an infection or immunization. It has been associated with multiple causes, including bacterial and viral infections. Hepatitis E virus (HEV) is a common cause of acute viral hepatitis that can rarely develop neurological complications. We report a case of a 72-year-old man who developed GBS secondary to an acute HEV infection. He presented with numbness and weakness of the lower limbs that rapidly evolved into respiratory failure requiring mechanical ventilation and intravenous immunoglobulin therapy (IVIg). This case adds to the literature on the association between HEV infection and GBS and the importance of early detection of this rapidly progressive condition. CI - Copyright (c) 2023, Rodrigues et al. FAU - Rodrigues, Ricardo A AU - Rodrigues RA AD - Internal Medicine, University Hospital Center of Coimbra, Coimbra, PRT. FAU - Sequeira, Miguel AU - Sequeira M AD - Intensive Medicine, University Hospital Center of Coimbra, Coimbra, PRT. FAU - Barros, Francisco AU - Barros F AD - Neurology, University Hospital Center of Coimbra, Coimbra, PRT. FAU - Alves, Telma AU - Alves T AD - Internal Medicine, University Hospital Center of Coimbra, Coimbra, PRT. FAU - Goncalves, Joao AU - Goncalves J AD - Internal Medicine, University Hospital Center of Coimbra, Coimbra, PRT. LA - eng PT - Case Reports DEP - 20231114 PL - United States TA - Cureus JT - Cureus JID - 101596737 PMC - PMC10719760 OTO - NOTNLM OT - acute viral hepatitis OT - auto-immune OT - demyelinating polyneuropathy OT - guillain barre's syndrome (gbs) OT - hepatitis e virus OT - hev OT - polyneuropathy COIS- The authors have declared that no competing interests exist. EDAT- 2023/12/15 06:42 MHDA- 2023/12/15 06:43 PMCR- 2023/11/14 CRDT- 2023/12/15 03:56 PHST- 2023/11/13 00:00 [accepted] PHST- 2023/12/15 06:43 [medline] PHST- 2023/12/15 06:42 [pubmed] PHST- 2023/12/15 03:56 [entrez] PHST- 2023/11/14 00:00 [pmc-release] AID - 10.7759/cureus.48778 [doi] PST - epublish SO - Cureus. 2023 Nov 14;15(11):e48778. doi: 10.7759/cureus.48778. eCollection 2023 Nov.